Enter your username/e-mail and your new password will be send to you.
Title | European Research Infrastructure on Highly Pathogenic Agents 2 |
Grant Agreement Number | 689622 |
Funding Programmes | H2020 |
Budget | Total: €1,514,853.75, EC Contribution: €1,514,853.00 |
Dates | 01/01/2016 - 30/06/2017 |
Project URL | http://www.erinha.eu/ |
Scientific Domain |
Biological and Medical Sciences |
Type Of Project | CSA |
Abstract | ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administrative and technical maturity necessary to complete the establishment of the Research Infrastructre and ensure that the operation phase can begin in 2018. ERINHA2 will therefore finalise the decision to use the status of an association and prepare the necessary legal document to register the RI depending on the country voted on to host the Central Coordinating Unit. ERINHA2 will prepare all procedures and protocols (human resources, IPR, ethics) needed to effectively operate the RI. The financial and business plans prepared in ERINHA (PP1) will updated and presented to national and international stakeholders to obtain their agreement to fund the infrastructure. An overarching group of activities - WP5, Stakeholders and commitment - will aim to accompany all partner countries in their efforts to obtain agreements and funding. This WP5 will ensure all relevant stakeholders and potential users are informed of the progress, services and benefits of ERINHA. The utlimate outcome of ERINHA2 will be the signtature of the ERINHA statutes among the founding countries to officially establish the RI and enter into the construction phase. |
Coordinator
(Organisation name and Country, EC contribution to budget) |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE , France, (€440,881.45) |
Partners
(Organisation name and Country, EC contribution to budget) |
FRIEDRICH LOEFFLER INSTITUT - BUNDESFORSCHUNGSINSTITUT FUER
TIERGESUNDHEIT, Germany, (€30,400.00) PHILIPPS UNIVERSITAET MARBURG, Germany, (€37,187.50) INSTITUTO DE SALUD CARLOS III, Spain, (€141,562.50) Országos Epidemiológiai Központ, Hungary, (€36,578.75) INSERM - TRANSFERT SA, France, (€173,437.50) INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE, Portugal, (€40,287.50) ISTITUTO NAZIONALE MALATTIE INFETTIVE L.SPALLANZANI - IRCCS, Italy, (€39,250.00) HELLENIC PASTEUR INSTITUTE, Greece, (€45,187.50) ROBERT KOCH-INSTITUT, Germany, (€43,515.00) PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE, Belgium, (€99,376.25) MEDIZINISCHE UNIVERSITAT GRAZ, Austria, (€58,500.00) BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN, Germany, (€38,312.50) SPITALUL CLINIC DR VICTOR BABES BUCURESTI - SVB, Romania, (€32,562.50) Department of Health, United Kingdom, (€252,872.50) FOLKHALSOMYNDIGHETEN, Sweden, (€60,000.00) |